Pharmaceuticals

With a new collaboration with Pfizer announced, ORIC Pharmaceuticals shares have jumped by more than 50% on Thursday. But is ORIC stock a good...

Horizon Therapeutics (NASDAQ: HZNP) has seen its share price leap on the back of M&A news, but does that mean HZNP stock is a good investment?

Iveric Bio Inc (NASDAQ: ISEE) has seen its share price leap following a new FDA designation. However, with good news for a key competitor emerging...

The IPOs to look out for this week include cancer treatment outfit Genelux Corporation and medicine development and AI specialist BullFrog AI.

Many shroom stocks are attempting to bring magic mushrooms to consumers, but will this trio of psilocybin specialists also bring magic to...

What can biotech penny stocks do for you? While investors might be attracted by the potential for outsize returns, there are serious risks to...

Though ESSA Pharma Inc (NASDAQ: EPIX) saw its share price soar last week on strong pre-clinical news, a trial hiccup is giving investors jitters....

DICE share price rebounds as positive top line data from psoriasis phase 1 clinical trial delights.

Having just signed a major deal with a top pharma player, Provention Bio (NASDAQ: PRVB) is attracting investors' attention. But is PRCB stock a...

Amylyx Pharmaceuticals (NASDAQ: AMLX) stock is rising in after-hours trading on FDA approval of its ALS drug.

Are biopharma stocks the missing secret ingredient for your portfolio? Read on to find out why investing in biopharma could leave you with sizeable...

Biopharmaceutical outfit Ardelyx Inc (NASDAQ: ARDX) has recently started selling its first treatment, but is ARDX stock worth backing?

Regen BioPharma recently filed a patent related to a mRNA cancer immunotherapeutic vaccine. Does the market growth potential make RGBP a good...

Here we take a look at Atai Life Sciences stock and examine whether the company's stock of alternative and psychedelic treatment candidates makes...

Eton Pharmaceuticals (NASDAQ: ETON) saw its stock price rise this morning following FDA approval for its epilepsy treatment. But is the stock a...

Pliant Therapeutics saw its share price more than double first thing on Monday after reporting positive feedback from trials of its pulmonary...